[ad_1]
A study by researchers at the University of Toronto, Canada, published in the latest issue of the Journal of Neuroscience, found that the drug letrozole, which is used to treat breast cancer, can lead to Brain dysfunction in patients who use it, the Anatolia News Agency reported.
Lactoseol is used to prevent the recurrence of breast cancer by intervening in the production of estrogen, which interferes with its production to prevent the spread of breast tumors.
Few people are aware of the effect of the drug on the brain, despite the common side effects of the drug, such as mood disorders and its effects on memory, reported in previous experiments with humans and humans. animals.
The study investigated the effects of LTO on a group of monkeys with breast cancer and found that the drug affected the function of hippocampal neurons in the brain and led to an imbalance in spatial memory.
"The results of this study led us to further our research on estrogen-targeted breast cancer treatments to monitor their effects on the brain," said Dr. Nicole Gervais, lead author.
Breast cancer is the most common type of tumor among women in the world, and in the Middle East in particular. About 1.4 million new cases are diagnosed each year, claiming more than 450,000 lives each year worldwide, according to the International Agency for Research on Cancer. From the World Health Organization.
[ad_2]
Source link
